Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Clinical trial NCT05403580 · WITHDRAWN

Trial details

NCT number: NCT05403580
Sponsor: Mayo Clinic
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Hematopoietic and Lymphoid Cell Neoplasm

Start date: 2022-06-03
Primary completion: 2023-12-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.